CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents
CD34+CD38-白血病干细胞可预测接受非强化低甲基化药物治疗的急性髓系白血病患者的临床结局。
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02539-0
Reuvekamp, Tom; Ngai, Lok Lam; den Hartog, Daphne; Carbaat-Ham, Jannemieke; Fayed, Mona M H E; Scholten, Willemijn J; Mocking, Tim R; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Breems, Dimitri; van Lammeren-Venema, Danielle; Boersma, Rinske; Ossenkoppele, Gert J; van de Loosdrecht, Arjan A; Bachas, Costa; Huls, Gerwin; de Leeuw, David C; Cloos, Jacqueline
发育与干细胞
表观遗传
白血病
CD3
CD34
CD38
干细胞
细胞生物学